The “North America Drug Delivery Market – Trends and Forecast to 2024” report has been added to Research and Markets’ offering.
The North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024, at a CAGR of 6.4% during the forecast period of 2017 to 2024.
Scope of the Report
– North America Drug Delivery Market is segmented based on product type, end-user, distribution channel, and geography.
– On the basis of route of administration the drug delivery market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal.
– Based on distribution channel the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy.
– On the basis of end users the market is segmented into hospitals, over the counter, clinics, home healthcare, community healthcare, and others.
– The North America drug delivery market is segmented into 3 major countries such as U.S., Canada, and Mexico.
Market Overview
Drivers
– Rising Prevalence of Chronic Disease Such as Diabetes
– Growth in the Development of Biologics
– Technological Development
Restraints
– Risk of Needle-Stick Injuries and Side Effects
Opportunities
– Rising Acceptance of Self Administering Drugs
– Rising Demand for Biosimilars and Generic Drugs
– Trend of Merger and Acquisitions, and Collaborations
– Focus on Patient Needs
– Developing and New Emerging Revenue Pockets
Threats
– Product Recalls
– Stringent Regulatory and High Pricing
– Patent Expiry and Patent Cliff
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. North America Drug Delivery Devices Market, by Product Type
7. North America Drug Delivery Devices Market, by End User
8. North America Drug Delivery Devices Market, by Distribution Channel
9. Drug Delivery Market, by Geography
10. North America Drug Delivery Devices Market, Company Share
11. Company Profiles
– F. Hoffmann-La Roche AG
– Pfizer Inc.
– GlaxoSmithKline plc.
– Merck & Co.
– Sanofi
– Antares Pharma
– 3M
– Becton Dickinson and Company
– Nemera
– Cima Labs Inc.
– Dali Medical Devices
– Alkermes
– Foamis
– Ypsomed
– Skyepharma AG
– Valeant Pharmaceuticals DSM Biomedical
– Catalent Inc.
For more information about this report visit https://www.researchandmarkets.com/research/6fscdf/north_america